Prévisions du marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord jusqu\'en 2030 – Analyse régionale – par services (services commerciaux et services non commerciaux), modules (modules syndiqués et modules dédiés), domaine thérapeutique (troubles cardiovasculaires, oncologie, troubles métaboliques, neurologie, maladies orthopédiques , maladies infectieuses et autres) et utilisateur final (sociétés biopharmaceutiques et sociétés pharmaceutiques)

Le marché nord-américain des organisations de vente sous contrat pharmaceutique devrait passer de 3 987,29 millions de dollars américains en 2022 à 7 614,12 millions de dollars américains d’ici 2030. Il devrait enregistrer un TCAC de 8,4 % de 2022 à 2030. L’intégration croissante des technologies numériques stimule l’Amérique du Nord. Marché des organisations de vente sous contrat pharmaceutique Le déploiement accru des technologies numériques alimente une poussée transformationnelle sur le marché des organisations de vente sous contrat pharmaceutique (CSO). Ce changement fondamental met en évidence la nécessité d’une réponse tactique à l’évolution dynamique du marché pharmaceutique. L’intégration d’outils et de technologies numériques dans les OSC est un élément essentiel pour rationaliser les opérations de vente, augmenter la productivité et naviguer dans les complexités d’un environnement de santé de plus en plus numérisé. Grâce à des outils avancés de gestion de la relation client, à l\'intelligence artificielle et à l\'analyse des données, les OSC peuvent obtenir des informations précieuses, personnaliser leurs stratégies de vente et établir des relations plus approfondies avec les professionnels de la santé. En plus d’accélérer la transmission des informations, l’intégration transparente des plateformes numériques permet une adaptabilité en temps réel aux tendances du marché et aux évolutions législatives. Ce changement technologique dans le paysage des OSC pharmaceutiques représente plus qu’une simple mode ; cela représente une redéfinition fondamentale de la manière dont les tactiques de vente sont développées et mises en œuvre. L’adoption des technologies numériques place les OSC à la pointe de l’innovation. Il promeut un environnement plus réactif qui s’aligne sur la transformation numérique plus large qui balaye le secteur de la santé. Le marché est positionné pour une croissance soutenue alors que les OSC pharmaceutiques continuent d’utiliser la puissance de la numérisation, propulsées par une convergence d’expertise technologique, d’agilité stratégique et une conscience claire des exigences contemporaines de l’écosystème pharmaceutique. Aperçu du marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord Le marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord est segmenté entre les États-Unis, le Canada et le Mexique. En 2022, les États-Unis détenaient la plus grande part de marché dans cette région et devraient maintenir leur domination au cours de la période de prévision. Le marché des organisations de vente sous contrat de produits pharmaceutiques en Amérique du Nord devrait croître en raison de l\'adoption de nouvelles technologies par les organisations de vente sous contrat, de l\'accent croissant mis par les sociétés pharmaceutiques sur l\'augmentation des ventes de petites molécules et de médicaments biopharmaceutiques, et d\'une attention accrue portée à la réduction des ventes. la réduction des coûts engagés par les opérations de vente internes sont les principaux facteurs qui stimulent la croissance du marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord. Le nombre de lancements de nouveaux médicaments a augmenté au fil du temps. Selon un rapport d\'IQVIA sur les tendances en matière de R&D, 84 nouveaux composés actifs ont été introduits dans le monde en 2021, soit deux fois plus qu\'au cours des 5 années précédentes. La demande de services de vente sous contrat devrait augmenter avec l’augmentation des sorties de médicaments à l’échelle internationale. L’Amérique du Nord représente la plus grande part du marché des organisations de vente sous contrat pharmaceutique. Des acteurs clés tels que EPS Corp. ; IQVIA, Inc. ; et Axxelus alimentent le marché dans cette région. Chiffre d’affaires et prévisions du marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord jusqu’en 2030 (en millions de dollars américains) Segmentation du marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord Le marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord est segmenté en services, modules, domaine thérapeutique, utilisateur final et pays. Sur la base des services, le marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord est divisé en services commerciaux et services non commerciaux. Le segment des services commerciaux détenait une part plus importante du marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord en 2022. Sur la base des modules, le marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord est divisé en modules syndiqués et modules dédiés. Le segment des modules syndiqués détenait une part plus importante du marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord en 2022. Sur la base du domaine thérapeutique, le marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord est segmenté en troubles cardiovasculaires, oncologie, troubles métaboliques, neurologie, maladies orthopédiques, maladies infectieuses. maladies et autres. Le segment de l’oncologie détenait la plus grande part du marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord en 2022. En fonction de l’utilisateur final, le marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord est divisé en sociétés biopharmaceutiques et sociétés pharmaceutiques. Le segment des sociétés pharmaceutiques détenait une part plus importante du marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord en 2022. En fonction des pays, le marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord est segmenté entre les États-Unis, le Canada et le Mexique. Les États-Unis ont dominé le marché nord-américain des organisations de vente sous contrat de produits pharmaceutiques en 2022. Aenova Holding GmbH, Axxelus Inc, CMIC Holdings Co Ltd, IQVIA Holdings Inc, Peak Pharma Solutions Inc, Pfizer Inc, Promoveo Health LLC, QFR Solutions LLC, Sales Focus Inc, et Syneos Health Inc font partie des principales sociétés opérant sur le marché nord-américain des organisations de vente de produits pharmaceutiques sous contrat.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

5. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Integration of Digital Technologies

5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products

5.2 Key Market Restraints

5.2.1 Quality Issues Associated with Outsourcing

5.3 Key Market Opportunities

5.3.1 Rising Use of Telemedicine and Remote Detailing

5.4 Key Future Trends

5.4.1 Expansion in Emerging Markets

5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - North America Market Analysis

6.1 North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview

7.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

7.3 Commercial Services

7.3.1 Overview

7.3.2 Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Commercial Services

7.4.1 Overview

7.4.2 Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview

8.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

8.3 Syndicated Modules

8.3.1 Overview

8.3.2 Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Dedicated Modules

8.4.1 Overview

8.4.2 Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview

9.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

9.3 Cardiovascular Disorders

9.3.1 Overview

9.3.2 Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Metabolic Disorders

9.5.1 Overview

9.5.2 Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Neurology

9.6.1 Overview

9.6.2 Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.7 Orthopaedic Diseases

9.7.1 Overview

9.7.2 Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.8 Infectious Diseases

9.8.1 Overview

9.8.2 Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

10.3 Biopharmaceutical Companies

10.3.1 Overview

10.3.2 Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Pharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 North America

11.1.1.1 North America Pharmaceutical Contract Sales Organizations Market, by Country

11.1.1.2 US

11.1.1.2.1 US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.2 US: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.2.3 US: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.2.4 US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.2.5 US: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.3 Canada

11.1.1.3.1 Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.2 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.3.3 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.3.4 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.3.5 Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.4 Mexico

11.1.1.4.1 Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.4.2 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.4.3 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.4.4 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.4.5 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview

12.2 Growth Strategies

12.2.1 Overview

13. Company Profiles

13.1 CMIC Holdings Co Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Axxelus Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 IQVIA Holdings Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Peak Pharma Solutions Inc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QFR Solutions LLC

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Promoveo Health LLC

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Syneos Health Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Aenova Holding GmbH

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Pfizer Inc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Sales Focus Inc

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

List of Tables

Table 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation

Table 2. US: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 3. US: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 4. US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 5. US: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 6. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 7. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 8. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 9. Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 10. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 11. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 12. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 13. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market

Table 15. Glossary of Terms, North America Pharmaceutical Contract Sales Organizations Market

List of Figures

Figure 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation, By Country

Figure 2. North America - PEST Analysis

Figure 3. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

Figure 6. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

Figure 7. Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

Figure 10. Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

Figure 13. Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 21. Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. North America Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue (2022) (US$ Million)

Figure 24. North America Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)

Figure 25. US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

1. Aenova Holding GmbH

2. Axxelus Inc

3. CMIC Holdings Co Ltd

4. IQVIA Holdings Inc

5. Peak Pharma Solutions Inc

6. Pfizer Inc

7. Promoveo Health LLC

8. QFR Solutions LLC

9. Sales Focus Inc

10. Syneos Health Inc

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Pharmaceutical Contract Sales Organizations Market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the North America Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For North America Pharmaceutical Contract Sales Organizations Market

WHAT'S INCLUDED IN FULL REPORT